Saladax Biomedical (NASDAQ: SLNX) Expands Global Access to Therapeutic Drug Monitoring

April 7, 2026

Market Overview Saladax Biomedical (NASDAQ: SLNX) is advancing its position in the therapeutic drug monitoring (TDM) diagnostics space, focusing on psychiatry and oncology markets. The company’s shares are drawing attention as it extends the availability of its assays internationally, assisting healthcare providers in personalizing medication dosages for improved patient outcomes. This move signals growing adoption of precision medicine approaches targeting highly variable drug responses in clinical settings. By expanding access…

Read More >>